Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of Caloric Intake in Obesity via Pharmacologic Modulation of Gastric Emptying
2004-004066-32Phase 2Completed
- Sponsor
- Silvia Delgado Aros
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of erythromycin in obesity and Overweight, sponsored by Silvia Delgado Aros. Primary endpoint: Acceleration of gastric emptying. Started May 2006; status: completed.
02
Drugs
erythromycin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on 2004-004066-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004066-32.